.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Deloitte
Daiichi Sankyo
Julphar
Accenture
Merck
Boehringer Ingelheim
Healthtrust
Harvard Business School

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020554

« Back to Dashboard
NDA 020554 describes DOVONEX, which is a drug marketed by Leo Pharm and Leo Pharma As and is included in three NDAs. It is available from four suppliers. Additional details are available on the DOVONEX profile page.

The generic ingredient in DOVONEX is calcipotriene. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.

Summary for NDA: 020554

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Dermatological Agents

Pharmacology for NDA: 020554

Ingredient-typeVitamin D

Suppliers and Packaging for NDA: 020554

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOVONEX
calcipotriene
CREAM;TOPICAL 020554 NDA Warner Chilcott (US), LLC 0430-3020 0430-3020-15 100 CARTON in 1 CASE (0430-3020-15) > 1 TUBE in 1 CARTON > 60 g in 1 TUBE
DOVONEX
calcipotriene
CREAM;TOPICAL 020554 NDA Warner Chilcott (US), LLC 0430-3020 0430-3020-17 50 CARTON in 1 CASE (0430-3020-17) > 1 TUBE in 1 CARTON > 120 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.005%
Approval Date:Jul 22, 1996TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020554

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma As
DOVONEX
calcipotriene
CREAM;TOPICAL020554-001Jul 22, 19964,866,048► Subscribe
Leo Pharma As
DOVONEX
calcipotriene
CREAM;TOPICAL020554-001Jul 22, 1996RE39706► Subscribe
Leo Pharma As
DOVONEX
calcipotriene
CREAM;TOPICAL020554-001Jul 22, 19965,763,426► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Teva
Boehringer Ingelheim
US Department of Justice
Accenture
Dow
Julphar
US Army
Medtronic
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot